Badgley Phelps Wealth Managers’s Nautilus Biotechnolgy NAUT Stock Holding History

Badgley Phelps Wealth Managers’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56.1K	Hold	30,000	–	–	﹤0.01%	331
2026 Q1	$116K	Hold	30,000	–	–	﹤0.01%	327
2025 Q4	$58.5K	Hold	30,000	–	–	﹤0.01%	325
2025 Q3	$25.3K	Hold	30,000	–	–	﹤0.01%	296
2025 Q2	$21.7K	Hold	30,000	–	–	﹤0.01%	296
2025 Q1	$25.8K	Hold	30,000	–	–	﹤0.01%	298
2024 Q4	$50.4K	Hold	30,000	–	–	﹤0.01%	287
2024 Q3	$85.5K	Hold	30,000	–	–	﹤0.01%	290
2024 Q2	$70.2K	Buy	+30,000	New	+$78.3K	﹤0.01%	254

Other funds holding NAUT

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Badgley Phelps Wealth Managers's NAUT Position: Q2 2026 in Review

Badgley Phelps Wealth Managers held its Nautilus Biotechnolgy (NAUT) position steady in Q2 2026 at 30,000 shares worth $56.1K. The position accounts for ﹤0.01% of the portfolio, ranked #331.

Badgley Phelps Wealth Managers first reported a position in NAUT in Q2 2024 and has held it in 9 quarters since. The position peaked at $116K in Q1 2026. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

Badgley Phelps Wealth Managers held 30,000 shares of Nautilus Biotechnolgy worth $56.1K as of Q2 2026.
Badgley Phelps Wealth Managers left its Nautilus Biotechnolgy share count unchanged in Q2 2026.
Nautilus Biotechnolgy made up ﹤0.01% of Badgley Phelps Wealth Managers's portfolio in Q2 2026, its #331 holding.
Badgley Phelps Wealth Managers first reported a position in Nautilus Biotechnolgy in Q2 2024 and has held it in 9 quarters since.
Badgley Phelps Wealth Managers's Nautilus Biotechnolgy position peaked at $116K in Q1 2026.
93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Badgley Phelps Wealth Managers's 13F filing for Q2 2026, filed 31 Jul 2026.